Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.

A new catheter from Johnson & Johnson MedTech is now approved to treat cardiac arrhythmias in Europe. Could FDA approval be on the horizon? 

Robotic-assisted mitral valve repair is associated with short-term outcomes comparable to conventional surgery, according to a new analysis of more than 40,000 patients. Robotic treatment also helps patients spend less time in the hospital, but the costs are much higher.

Cardiology is the medical speciality with the second most FDA clearances overall. 

Advanced practice providers continue to play a significant role in cardiology, helping care teams overcome the challenges brought on by an ongoing physician shortage, declining reimbursements and an aging population. 

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

James N. Kirkpatrick, MD, a cardiologist with the University of Washington, died unexpectedly on Jan. 1. Colleagues have shared loving tributes to Kirkpatrick, highlighting his passion for ethics and strong leadership skills.

Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead. 

CABG was associated with a 41% lower risk of long-term mortality than PCI in a new study of more than 57,000 patients. The full analysis was published in European Heart Journal.